782. Efficacy of the dAd5GNE Anti-Cocaine Vaccine in Models of “Binge” Cocaine Use

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)35795-1
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Combined Cocaine Hydrolase Gene Transfer and Anti-Cocaine Vaccine Synergistically Block Cocaine-Induced Locomotion

PLoS ONE
Multidisciplinary
2012English

Adenovirus Capsid-Based Anti-Cocaine Vaccine Prevents Cocaine From Binding to the Nonhuman Primate CNS Dopamine Transporter

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2013English

Effects of Galantamine on Cocaine Use in Chronic Cocaine Users

American Journal on Addictions
MedicineClinical PsychologyPsychiatryMental Health
2011English

The Treatment of Cocaine Use Disorder

Science advances
Multidisciplinary
2019English

A Recombinant Humanized Anti-Cocaine Monoclonal Antibody Alters the Urinary Clearance of Cocaine and Its Metabolites in Rats

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2018English

Underestimating Cocaine Use During Pregnancy.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1997English

The Use of Cocaine in the Morphine Habit: A Warning

BMJ
1907English

Efficacy of Disulfiram and Cognitive Behavior Therapy in Cocaine-DependentOutpatients

Archives of General Psychiatry
2004English

Atomoxetine Does Not Alter Cocaine Use in Cocaine Dependent Individuals: A Double Blind Randomized Trial

Drug and Alcohol Dependence
PsychiatryToxicologyMental HealthPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy